| Clinical data | |
|---|---|
| ATC code |
|
| Identifiers | |
| |
| CAS Number | |
| PubChemCID | |
| ChemSpider |
|
| UNII | |
| ChEMBL | |
| CompTox Dashboard(EPA) | |
| ECHA InfoCard | 100.048.694 |
| Chemical and physical data | |
| Formula | C18H17ClN2O3 |
| Molar mass | 344.80 g·mol−1 |
| 3D model (JSmol) | |
| |
| |
| | |
Arfendazam (INN)[1] is a drug which is abenzodiazepine derivative. Arfendazam is a 1,5-benzodiazepine, with the nitrogen atoms located at positions 1 and 5 of the diazepine ring, and so is most closely related to other 1,5-benzodiazepines such asclobazam.
Arfendazam hassedative andanxiolytic effects similar to those produced by other benzodiazepine derivatives, but is apartial agonist atGABAA receptors, so the sedative effects are relatively mild and it producesmuscle relaxant effects only at very high doses.[2][3]
Arfendazam produces an activemetabolitelofendazam, which is thought to be responsible for part of its effects.[4]